business

Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn - Financial Times

US company is attempting to acquire the maker of a new treatment for pancreatic cancer

By:Patrick Temple-West, Oliver Barnes
Source:Financial Times
Published:
Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn - Financial Times
was $409now $149 for your first year Delivery Monday - Saturday, including FT Weekend and FT Digital Edition: all the content of the FT newspaper on any device. Savings based on annual price.
    <… [+221 chars]

Related News